Many patients undergoing surgery use naturopathic drugs, including fish oil. Fish oil has been reported to increase bleeding in patients through inhibiting platelet aggregation and prolonging of clot formation time. The Swedish Medical Products Agency recommends that patients stop taking the naturopathic medicines including fish oil two weeks prior planed surgery. The aim of this study is to examine the effects of fish oil given to healthy volunteers using point of care coagulation assessment and flow dependent Cellix instrument before and after intake of fish oil.
Healthy volunteers will be given maximum dose of fish oil for 7 days. Blood samples will be collected before and immediately after the 7 days of intake and analysed using point of care coagulation assessment instruments and flow dependent platelet aggregation using a microfluid flow controlled system (Cellix). For point of care coagulation assessment the multiple electrode platelet aggregometer Multiplate, the viscoelastic rotational thromboelastometers ROTEM and Sonoclot will be used. Flow cytometry may also be utilized.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
12
Blood samples before and after 10 day intake of maximum dose fish oil
Intensive and perioperative care. Skåne University Hospital. Lund
Lund, Skåne County, Sweden
Thrombocyte aggregation measured with multiple electrode aggregometry
Multiple electrode aggregometry gives a area under the curve proportional to thrombocyte aggregation
Time frame: Change of thrombocyte aggregation directly after intake period of 7 days compared to baseline
Thrombocyte aggregation measured with Cellix's microfluidic pumps and biochips
Cellix's microfluidic pumps and biochips gives an thrombosis area proportional to thrombocyte aggregation
Time frame: Change of thrombocyte aggregation directly after intake period of 7 days compared to baseline
Coagulation measured with the viscohemostatic instrument ROTEM
Viscohemostatic instrument
Time frame: Change of coagulation directly after intake period of 7 days compared to baseline
Coagulation measured with the viscohemostatic instrument and Sonoclot
Viscohemostatic instrument
Time frame: Change of coagulation directly after intake period of 7 days compared to baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.